Robert Andrade - 22 May 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Andrade
Issuer symbol
FENC
Transactions as of
22 May 2025
Net transactions value
$0
Form type
4
Filing time
23 May 2025, 16:20:06 UTC
Previous filing
19 May 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Andrade Robert CHIEF FINANCIAL OFFICER C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK /s/ Robert Andrade 23 May 2025 0001468308

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $41,922 +8,220 +5.5% $5.10 158,520 22 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise $41,922 -8,220 -0.96% $5.10 850,751 22 May 2025 Options 8,220 $5.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.